EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Complete response to bevacizumab plus irinotecan in patients with rapidly progressive GBM: Cases report and literature review

Oguz Ozel, Mehmet Kurt, Oguzhan Ozdemir, Jale Bayram, Huseyin Akdeniz, Dogan Koca

Journal of Oncological Sciences · 2016

DOI: 10.1016/j.jons.2016.07.009 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Oncological Sciences, 2016. Verfasst von Oguz Ozel und 5 weiteren Autor:innen. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Ozel, O., Kurt, M., Ozdemir, O., Bayram, J., Akdeniz, H., & Koca, D. (2016). Complete response to bevacizumab plus irinotecan in patients with rapidly progressive GBM: Cases report and literature review. Journal of Oncological Sciences. https://doi.org/10.1016/j.jons.2016.07.009

Vancouver

Ozel O, Kurt M, Ozdemir O, Bayram J, Akdeniz H, Koca D. Complete response to bevacizumab plus irinotecan in patients with rapidly progressive GBM: Cases report and literature review. Journal of Oncological Sciences. 2016. doi:10.1016/j.jons.2016.07.009

BibTeX
@article{Ozel2016,
  author = {Ozel, Oguz and Kurt, Mehmet and Ozdemir, Oguzhan and Bayram, Jale and Akdeniz, Huseyin and Koca, Dogan},
  title = {Complete response to bevacizumab plus irinotecan in patients with rapidly progressive GBM: Cases report and literature review},
  journal = {Journal of Oncological Sciences},
  year = {2016},
  doi = {10.1016/j.jons.2016.07.009}
}
Kostenlos starten →